Transglutaminase: New insights into gelatin nanoparticle cross-linking

References

• Aimi M, Nemori R, Kojima M, Kishima M, 2006. Protein nanoparticles for drug delivery. Fujifilm Corporation, Japan. 2006-JP325987[2007072982], WO 20070628
   Google Scholar
• Aimi M, Nemori R, Miyashita Y, Yokoyama H, 2007. Enzymatically crosslinked protein nanoparticles. Fujifilm Corporation, Japan. 2007-JP51856[2007086613], 26, 20070802
   Google Scholar
• Bae HJ, Darby D, Kimmel R, Park HJ, Whiteside W. Effects of transglutaminase-induced cross-linking on properties of fish gelatin-nanoclay composite film. Food Chem 2009; 114(1)180–9
   Google Scholar
• Ballantyne B, Jordan SL. Toxicological, medical, and industrial hygiene aspects of glutaraldehyde with particular reference to its biocidal use in cold sterilization procedures. J Appl Toxicol 2001; 21(2)131–51
   PubMed Web of Science ®Google Scholar
• Barbetta A, Massimi M, Devirgiliis LC, Dentini M. Enzymatic cross-linking versus radical polymerization in the preparation of gelatin polyHIPEs and their performance as scaffolds in the culture of hepatocytes. Biomacromolecules 2006; 7(11)3059–68
   PubMed Web of Science ®Google Scholar
• Bertoni F, Barbani N, Giusti P, Ciardelli G. Transglutaminase reactivity with gelatine: Perspective applications in tissue engineering. Biotechnol Lett 2006; 28(10)697–702
   PubMed Web of Science ®Google Scholar
• Besheer A, Hertel TC, Kressler J, Maeder K, Pietzsch M. Enzymatically catalyzed HES conjugation using microbial transglutaminase: Proof of feasibility. J Pharm Sci 2009; 98(11)4420–8
   PubMedGoogle Scholar
• Boenisch MP, Huss M, Weitl K, Kulozik U. Transglutaminase cross-linking of milk proteins and impact on yoghurt gel properties. Int Dairy J 2007; 17(11)1360–71
   Google Scholar
• Bourquin C, Anz D, Zwiorek K, Lanz AL, Fuchs S, Weigel S, Wurzenberger C, von der Borch P, Golic M, Moder S, et al. Targeting CpG oligonucleotides to the lymph node by nanoparticles elicits efficient antitumoral immunity. J Immunol 2008; 181(5)2990–8
   PubMed Web of Science ®Google Scholar
• Broderick EP, O’Halloran DM, Rochev YA, Griffin M, Collighan RJ, Pandit AS. Enzymatic stabilization of gelatin-based scaffolds. J Biomed Mater Res B Appl Biomater 2005; 72(1)37–42
   PubMedGoogle Scholar
• Chau DYS, Collighan RJ, Verderio EAM, Addy VL, Griffin M. The cellular response to transglutaminase-cross-linked collagen. Biomaterials 2005; 26(33)6518–29
   PubMed Web of Science ®Google Scholar
• Coester C. Development of a new carrier system for oligonucleotides and plasmids based on gelatin nanoparticles. New Drugs 2003; 1: 14–17
   Google Scholar
• Coester CJ, Langer K, Von Briesen H, Kreuter J. Gelatin nanoparticles by two step desolvation-a new preparation method, surface modifications and cell uptake. J Microencapsul 2000; 17(2)187–93
   PubMed Web of Science ®Google Scholar
• Collighan RJ, Griffin M. Transglutaminase 2 cross-linking of matrix proteins: Biological significance and medical applications. Amino Acids 2009; 36(4)659–70
   PubMed Web of Science ®Google Scholar
• Cui L, Du G, Zhang D, Fan X, Chen J. Stability and conformational changes of transglutaminase from Streptomyces hygroscopicus in ethanol-aqueous medium. Process Biochem, (Amsterdam, The Netherlands) 2008; 43(8)887–91
   Google Scholar
• de Carvalho RA, Grosso CRF. Characterization of gelatin based films modified with transglutaminase, glyoxal and formaldehyde. Food Hydrocoll 2004; 18(5)717–26
   Web of Science ®Google Scholar
• Folk JE, Cole PW. Transglutaminase: Mechanistic features of the active site as determined by kinetic and inhibitor studies. Biochim Biophys Acta 1966; 122: 244–64
   PubMed Web of Science ®Google Scholar
• Fraunhofer W, Winter G, Coester C. Asymmetrical flow field-flow fractionation and multiangle light scattering for analysis of gelatin nanoparticle drug carrier systems. Anal Chem 2004; 76(7)1909–20
   PubMed Web of Science ®Google Scholar
• Fuchs S, Winter G, Coester C. Ultrasonic resonator technology as a new quality control method evaluating gelatin nanoparticles. J Microencapsul 2010; 27(3)242–52
   PubMed Web of Science ®Google Scholar
• Griffin M, Casadio R, Bergamini CM. Transglutaminases: Nature's biological glues. Biochem J 2002; 368(2)377–96
   PubMed Web of Science ®Google Scholar
• Heidebach T, Foerst P, Kulozik U. Transglutaminase-induced caseinate gelation for the microencapsulation of probiotic cells. Int Dairy J 2008; 19(2)77–84
   Google Scholar
• Lantto R. Protein cross-linking with oxidative enzymes and transglutaminase. Effects in meat protein systems. VTT Publ 2007; 642: 1–114
   Google Scholar
• Marx CK, Hertel TC, Pietzsch M. Soluble expression of a pro-transglutaminase from Streptomyces mobaraensis in Escherichia coli. Enzyme Microb Technol 2007; 40(6)1543–50
   Google Scholar
• Marx CK, Hertel TC, Pietzsch M. Purification and activation of a recombinant histidine-tagged pro-transglutaminase after soluble expression in Escherichia coli and partial characterization of the active enzyme. Enzyme Microb Technol 2008; 42(7)568–75
   Google Scholar
• Plishker MF, Thorpe JM, Goldsmith LA. Human epidermal transglutaminase: Stimulation by trypsin, organic solvents, and chaotropic salts. Arch Biochem Biophys 1978; 191(1)49–58
   PubMedGoogle Scholar
• Torchilin VP. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J 2007; 9(2)E128–47
   PubMed Web of Science ®Google Scholar
• Van Luyn MJA, Van Wachem PB, Dijkstra PJ, Olde Damink LHH, Feijen J. Calcification of subcutaneously implanted collagens in relation to cytotoxicity, cellular interactions and crosslinking. J Mater Sci Mater Med 1995; 6(5)288–96
   Google Scholar
• Weber C, Coester C, Kreuter J, Langer K. Desolvation process and surface characterization of protein nanoparticles. Int J of Pharmaceuticals 2000; 194(1)91–102
   PubMed Web of Science ®Google Scholar
• Wilms B, Hauck A, Reuss M, Syldatk C, Mattes R, Siemann M, Altenbuchner J. High-cell-density fermentation for production of L-N-carbamoylase using an expression system based on the Escherichia coli rhaBAD promoter. Biotechnol Bioeng 2001; 73(2)95–103
   PubMedGoogle Scholar
• Yoon JH, McKenzie D. A comparison of the activities of three beta-galactosidases in aqueous-organic solvent mixtures. Enzyme Microb Technol 2005; 36(4)439–46
   Google Scholar
• Zhu Y, Tramper J. Novel applications for microbial transglutaminase beyond food processing. Trends Biotechnol 2008; 26(10)559–65
   PubMedGoogle Scholar
• Zillies JC, Zwiorek K, Winter G, Coester C. Method for quantifying the PEGylation of gelatin nanoparticle drug carrier systems using asymmetrical flow field-flow fractionation and refractive index detection. Anal Chem 2007; 79(12)4574–80
   PubMedGoogle Scholar
• Zwiorek K, 2006. Gelatin nanoparticles as delivery system for nucleotide-based drugs. Thesis, Ludwig Maximilians University, Munich
   Google Scholar
• Zwiorek K, Bourquin C, Battiany J, Winter G, Endres S, Hartmann G, Coester C. Delivery by cationic gelatin nanoparticles strongly increases the immunostimulatory effects of CpG oligonucleotides. Pharm Res 2008; 25(3)551–62
   PubMed Web of Science ®Google Scholar
• Zwiorek K, Kloeckner J, Wagner E, Coester C. Gelatin nanoparticles as a new and simple gene delivery system. J Pharm Pharm Sci 2004; 7(4)22–8
   Google Scholar